Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: Prospective study in second Australian national blood pressure study cohort

Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Prahran 3181, Australia.
BMJ (online) (Impact Factor: 17.45). 11/2002; 325(7368):815. DOI: 10.1136/bmj.325.7368.815
Source: PubMed


To identify simple long term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in elderly patients in general practice.
Prospective cohort study.
169 general practices in Victoria, Australia.
503 patients aged 65-84 with treated hypertension who were withdrawn from all antihypertensive drugs and remained drug free and normotensive for an initial two week period; all were followed for a further 12 months.
Relative likelihood of maintaining normotension 12 months after drug withdrawal; relative likelihood of early return to hypertension after drug withdrawal.
The likelihood of remaining normotensive at 12 months was greater among younger patients (65-74 years), patients with lower "on-treatment" systolic blood pressure, patients on single agent treatment, and patients with a greater waist:hip ratio. The likelihood of return to hypertension was greatest for patients with higher "on-treatment" systolic blood pressure.
Age, blood pressure control, and the number of antihypertensive drugs are important factors in the clinical decision to withdraw drug treatment. Because of consistent rates of return to antihypertensive treatment, all patients from whom such treatment is withdrawn should be monitored indefinitely to detect a recurrence of hypertension.

Download full-text


Available from: Christopher M Reid, Oct 13, 2015
7 Reads
  • Source
    • "Stopping medications can be associated with adverse drug effects related to withdrawal (Woodward 2000), recurrence of the underlying condition (Nelson et al 2002), or alterations in the pharmacokinetics and pharmaco-dynamics of the patient’s other medications. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prescribing for older people is challenging because of the paucity of clinical trial evidence of therapeutic benefit in this population and the presence of evidence that older people are at increased risk of adverse drug reactions. The outcomes of pharmacotherapies in older people depend on age-related changes in both pharmacokinetics and pharmacodynamics. Of the pharmacokinetic changes, those in hepatic metabolism are the most significant. Recent advances in biogerontology have improved our understanding of changes that occur in hepatic pharmacokinetics in older people. Knowledge of age-related changes in hepatic metabolism can guide prescribing and help reduce the risk-benefit ratio of using medications in older people.
    Therapeutics and Clinical Risk Management 07/2005; 1(2):151-6. DOI:10.2147/tcrm. · 1.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Summary The decision on when to start drugs for the treatment of elevated blood pressure should be determined by an individual's absolute risk of having an adverse cardiovascular event. The choice of drug depends on its safety and effectiveness and its indications and contraindications for individual patients. most patients will require two or more drugs to reach their target blood pressure. The main classes of antihypertensive drugs are equally effective at reducing blood pressure, but beta blockers are no longer recommended as first-line treatment for most patients.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Project Report to Food Standards Agency
Show more